Bronze
Boditech Med Inc. has been developing products for in-vitro diagnostics anddiagnostic reagents for the past 20 years by pursuing the value of a companycalled "Respect for Life".In particular, more than 25,000 units of ichroma™ readers are installed andoperated world wide, and ichroma™ CRP (C-Reactive Protein) has secured itslargest market share in China, showing a unique competitiveness.Boditech Med Inc. is leading the way in exploring new markets through theautomation of on-site diagnosed immunodiagnostic devices and the development ofnew high-sensitive diagnostic reagents. We have built up our reputationsuccessfully by carrying out various national R&D projects based on solidtechnology, experience, and human resources accumulated over the years. Inaddition, Boditech Med Inc. is developing a smart production system thatintegrates digital technology and IT technology to flexibly manage the productionscale. All employees of Boditech Med Inc. are making every effort with pridethat we are the top leader of BT-IT convergence industry in Korea.
AFIAS-6 (AFIAS-automated fluorescent immunoassay system) is an automated fluorescent immunoassay system that uses blood, urine, and other samples to measure quantitatively or semi-quantitatively the concentration of targeted analyte. AFIAS all-in-one cartridges are designed to optimize the structure and operating principle of the reader. Its automated test process enables to carry out multiple simultaneous tests for six different samples. For some specified items such as TSH, CRP, PCT and HbA1c, small volume (10 μL or 50 μL) of whole blood from a finger or heel can be used for quantitative testing using a C-tip (capillary tip).